Reactive Lymphocytes in Blood Film of A COVID-19 Iraqi Patient: A Case Report

Al-Ani, Abdulsalam

Print ISSN: 2706-6207

Online ISSN: 2664-3154

Volume16, Issue2

Reactive Lymphocytes in Blood Film of A COVID-19 Iraqi Patient: A Case Report

Abdulsalam Al-Ani

Al- Anbar Medical Journal, 2020, Volume 16, Issue 2, Pages 50-52

Abstract

Approved diagnosis of coronavirus disease 2019 (COVID-19) depends on the golden-standard ofmolecular detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However,hematological parameters play a pivotal role in the diagnosis and progress of the disease. This casereport of a 51-year-old COVID-19 Iraqi male patient, showed the presence of reactive lymphocytesin his peripheral blood film. Although the presence of these cells was regarded as a hallmark incertain viral infections, this was a striking feature in comparison with coronavirus family infectionsother than caused by SARS-CoV-2. This hematological finding can play a role in COVID-19diagnosis as a feasible, rapid, and cheap tool, especially in low medical resources countries.

Keywords:

PDF (337 K)

1] WHO director-general’s opening remarks at the media
briefing on COVID-19 - 11 march, 2020. [Online].
[2] Y. Huanget al.Clinical characteristics of laboratory con-
firmed positive cases of SARS-CoV-2 infection in wuhan,
china: A retrospective single center analysis.Travel Med.
Infect. Dis., page 101606, 2020.
[3] R. Luet al.Genomic characterisation and epidemiology
of 2019 novel coronavirus: Implications for virus origins
and receptor binding.The Lancet, 395(10224):565–574,
2020.
[4] C. Huanget al.Clinical features of patients infected with
2019 novel coronavirus in wuhan, china.The Lancet,
395(10223):497506, 2020.
[5] P.Vetter,D.L.Vu,A.G.L’Huillier,M.Schibler,
L. Kaiser, and F. Jacquerioz. Clinical features of COVID-
19.The BMJ, 369(April):1–2, 2020.
[6] Y. Xionget al.Clinical and high-resolution ct features of
the COVID-19 infection: Comparison of the initial and
follow-up changes.Invest. Radiol., 55(6):332–339, 2020.
[7] B. M. Henry, M. H. S. De Oliveira, S. Benoit, M. Plebani,
and G. Lippi.Hematologic, biochemical and immune
biomarker abnormalities associated with severe illness
and mortality in coronavirus disease 2019 (COVID-19):
A meta-analysis.Clin. Chem. Lab. Med., 58(7):1021–
1028, 2020.
[8] J. Bao, C. Li, K. Zhang, H. Kang, W. Chen, and B. Gu.
Comparative analysis of laboratory indexes of severe
and non-severe patients infected with COVID-19.Clin.
Chim. Acta, 509(June):180–194, 2020.
[9] F. Wanget al.Characteristics of peripheral lymphocyte
subset alteration in COVID-19 pneumonia.J. Infect.
Dis., 221(11):1762–1769, 2020.
[10] M. Xiong, X. Liang, and Y. Wei.Changes in blood
coagulation in patients with severe coronavirus disease
2019 (COVID-19):A metaanalysis.Br. J. Haematol.,
189(6):1050–1052, 2020.
[11] T. Iba, J. H. Levy, M. Levi, and J. Thachil.Coagu-
lopathy in COVID-19.J. Thromb. Haemost., pages 0–2,
2020.
[12] I. Huang and R. Pranata. Lymphopenia in severe coron-
avirus disease-2019 (COVID-19): Systematic review and
meta-analysis.J. Intensive Care, 8(1):1–10, 2020.
[13] L. Tanet al.Lymphopenia predicts disease severity of
COVID-19:A descriptive and predictive study.Signal
Transduct. Target. Ther., 5(1):16–18, 2020.
[14] C. Lawrence. Diagnosis from the blood smear.N. Engl.
J. Med., 353(17):1862, 2005.
[15] B. J. Bain. Blood cell morphologyin health and disease.
Dacie and Lewis Practical Haematology, 12thed., B. a.
F. F. D. MD Emeritus S. M. LEWIS, Ed., China, Else-
vier Limited, pages 61–92, 2017.
[16] W. V. D. Meer. The divergent morphological classifica-
tion of variant lymphocytes in blood smears. May, 2014.
[17] M. W. Simon.The atypical lymphocyte.Int. Pediatr.,
18(1):20–22, 2003.
[18] T. E. M. a. K. E. Nichols. Infectious mononucleosis and
other epstein-barr virus related disorders.Wintrobe’s
Clin. Hematol. 14thed. Philadelphia, Wolters Kluwer,
pages 4207–4249, 2019.
[19] L. Datta and M. P. Menon. Plasmacytoid lymphocytes:
A clue to dengue diagnosis.Blood, 129(15):2202, 2017.
[20] W. J. Chng, H. C. Lai, A. Earnest, and P. Kuperan.
Haematological parameters in severe acute respiratory
syndrome.Clin. Lab. Haematol, 27(1):15–20, 2005.
[21] V. C. L. Chong, K. G. E. Lim, B. E. Fan, S. S. W. Chan,
K. H. Ong, and P. Kuperan.Reactive lymphocytes in
patients with Covid-19.Br. J. Haematol., 189(5):844,
2020.
[22] L. Fuet al.Clinical characteristics of coronavirus dis-
ease 2019 (COVID-19) in china:A systematic review
and meta-analysis.J. Infect., 80(6):656–665, 2020.
[23] H. Yun, Z. Sun, J. Wu, A. Tang, M. Hu, and Z. Xiang.
Laboratory data analysis of novel coronavirus (COVID-
19) screening in 2510 patients.Clin. Chim. Acta, 507:94–
97, 2020.
[24] W. Guanet al.Clinical characteristics of coronavirus
disease 2019 in china.N. Engl. J. Med., 382(18):1708–
1720, 2020.
[25] D. G ́erard, S. Henry, and B. Thomas. SARS-CoV-2: A
new aetiology for atypical lymphocytes.Br. J. Haema-
tol., 189(5):845, 2020.
[26] D. Foldes, R. Hinton, S. Arami, and B. J. Bain.Plas-
macytoid lymphocytes in SARS-CoV-2 infection (Covid-
19).Am. J. Hematol., 95(7):861–862, 2020.
[27] J. Osmanet al.Rapid screening of COVID-19 patients
using white blood cell scattergrams, a study on 381 pa-
tients.Br. J. Haematol., pages 2–6, 2020.

Article View: 16
PDF Download: 6